ERD

Sort by

European Partnerships

Show in overview

EU-Programme-Call

Show in overview

2 items found

Toggle all information

PAH-HOPE | New hope for the PAH patient: A Novel Therapeutic for Pulmonary Arterial Hypertension (PAH)

01-10-2018

-

31-03-2021

Show more information

Organisation ATXA THERAPEUTICS LTD

PAH-Advance | PAH-ADVANCE: Accelerating the Clinical Path of NTP42, a disease-modifying drug that will disrupt the future treatment of cardiopulmonary diseases, including pulmonary arterial hypertension (PAH).

01-01-2023

-

31-12-2023

Show more information

Organisation ATXA THERAPEUTICS LTD